Home > Products > API > Levofloxacin heMihydrate
Levofloxacin heMihydrate
  • Levofloxacin heMihydrateLevofloxacin heMihydrate

Levofloxacin heMihydrate

Product Name:Levofloxacin heMihydrate
Formulae hypotheticae: C18H22FN3O5
M. Pondus; 379.39
CAS Subcriptio Number: 138199-71-0

Model:CAS NO:138199-71-0

Mitte Inquisitionem

depictio producti

Levofloxacin heMihydrate

Product nomen:Levofloxacin heMihydratorum 138199-71-0
CAS No:138199-71-0
Specification: in domo

Nomen Levofloxacin heMihydrate
Synonyma LevofloacinImpurity16;levofloxacinhydrate;LEVOFLOXACINHCL;(s)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido(1,2,3- de)-1,4-benzoxazine-6-carboxylicacidhydrate(2:1); albookOFLOXACINHHYDROCHLORIDE;(S)-(-)-Ofloxacine; Levofloxacine;(-)-(s)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7- oxo-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylicacidhydrochloride
copyRight
M CAS # 59-02-9, Vitamin E, D-alpha-Tocopherol, (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
Formulae hypotheticae C18H22FN3O5
M. Pondus 379.39
CAS Subcriptio Number 138199-71-0


Pertractatio et repono
Cautiones pro tutum pertractatio
Bene ventilatas tractantem in loco. Apta tutela vestitus. Pelle et oculis contactum fuge. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Conditiones repono pro tuto, inter quaslibet incompatibilitates
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.

Imprimis usus finis (s): oeconomiae laboratoriae, ad investigationes scientificas et evolutionem tantum



Hot Tags: Levofloxacin heMihydrate, China, Suppliers, Manufacturers, Factory
Related Categoria
Mitte Inquisitionem
Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept